Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Total Current Liabilities: 2012-2025

Historic Total Current Liabilities for Enanta Pharmaceuticals (ENTA) over the last 13 years, with Sep 2025 value amounting to $48.6 million.

  • Enanta Pharmaceuticals' Total Current Liabilities fell 15.61% to $48.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.6 million, marking a year-over-year decrease of 15.61%. This contributed to the annual value of $48.6 million for FY2025, which is 15.61% down from last year.
  • Latest data reveals that Enanta Pharmaceuticals reported Total Current Liabilities of $48.6 million as of Q3 2025, which was up 8.99% from $44.5 million recorded in Q2 2025.
  • Enanta Pharmaceuticals' 5-year Total Current Liabilities high stood at $68.2 million for Q2 2023, and its period low was $23.0 million during Q4 2022.
  • Its 3-year average for Total Current Liabilities is $53.1 million, with a median of $54.6 million in 2024.
  • Per our database at Business Quant, Enanta Pharmaceuticals' Total Current Liabilities crashed by 39.30% in 2022 and then skyrocketed by 196.02% in 2023.
  • Over the past 5 years, Enanta Pharmaceuticals' Total Current Liabilities (Quarterly) stood at $37.9 million in 2021, then crashed by 39.30% to $23.0 million in 2022, then skyrocketed by 171.32% to $62.4 million in 2023, then fell by 21.40% to $49.0 million in 2024, then dropped by 15.61% to $48.6 million in 2025.
  • Its Total Current Liabilities stands at $48.6 million for Q3 2025, versus $44.5 million for Q2 2025 and $45.9 million for Q1 2025.